Super-speciality medicines play an indispensable role in addressing complex health issues, but they often remain ensnared in a web of accessibility, affordability, and reliability issues. MrMed wants to change that.
By 2050, #AntimicrobialResistance is expected to claim 10 million lives a year globally, more than cancer and diabetes combined, with most of this burden falling on low- and middle-income countries
By 2050, #AntimicrobialResistance is expected to claim 10 million lives a year globally, more than cancer and diabetes combined, with most of this burden falling on low- and middle-income countries